Jefferies Upgrades West Pharmaceutical (WST) to Buy as 'organic growth is correlated to injectable drug approvals'

February 7, 2024 3:05 AM EST Send to a Friend
(Updated - February 7, 2024 4:24 AM EST)

Jefferies analyst David Windley upgraded West Pharmaceutical (NYSE: WST) from Hold ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login